Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF) today announced its financial and operational results for the three months ended September 30, 2012 ("Q3 2012"). Q3 2012 Summary Achieved...

Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it will host a conference call for its Q3 2012 financial results on Wednesday, October 24, 2012 at 8:30AM ET. Q3 2012 CONFERENCE CALL

Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the Rodman & Renshaw 14th Annual Healthcare...

- In-license agreement for the Betesil® Patch to treat inflammatory skin conditions - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Aug. 7, 2012 /CNW/ - Cipher Pharmaceuticals Inc., (TSX:...

- Results highlighted by solid revenue growth and FDA approval of CIP-ISOTRETINOIN - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 25, 2012 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:...